34026 Federal Register / Vol. 86, No. 121 / Monday, June 28, 2021 / Notices 

ANNUALIZED BURDEN HOUR TABLE—Continued 

Forms 

(if necessary) 

Number of 

respondents 

Number of 

responses per 

respondents 

Average 

burden per 

response 

Total burden 

hours 

Focus groups—Instrument .............................................................................. 975 1 1.50 1,462.5 

Intercept interviews .......................................................................................... 5,250 1 5/60 437.50 

Cognitive testing of instruments—Screener .................................................... 150 1 10/60 25 

Cognitive testing of instruments—Cognitive test ............................................. 50 1 2.00 100 

Web-based surveys—Screener ....................................................................... 30,000 1 5/60 2,500 

Web-based surveys—Survey .......................................................................... 10,000 1 15/60 2,500 

Omnibus surveys ............................................................................................. 2,100 1 10/60 350 

Gatekeeper reviews ......................................................................................... 325 1 30/60 162.5 

Card sorting—Screener ................................................................................... 600 1 10/60 100 

Card sorting—Card sort ................................................................................... 200 1 1.00 200 

Usability and prototype testing of materials (print and web)—Screener ......... 1,800 1 10/60 300 

Usability and prototype testing of materials (print and web)—usability tests 600 1 1.00 600 

Total .......................................................................................................... ........................ ........................ ........................ 9,975.00 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2021–13737 Filed 6–25–21; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Announcement of Opportunity To 

Become a Healthy People 2030 

Champion 

AGENCY: Office of Disease Prevention 

and Health Promotion, Office of the 

Assistant Secretary for Health, Office of 

the Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The U.S. Department of 

Health and Human Services’ (HHS) 

Office of Disease Prevention and Health 

Promotion (ODPHP) invites public and 

private sector organizations that support 

Healthy People 2030 (HP2030), the 

nation’s disease prevention and health 

promotion plan, to become a Healthy 

People 2030 Champion (HP2030 

Champion). 

Eligibility: Any organization may 

apply to be a HP2030 Champion. The 

selected HP2030 Champions will be 

recognized for their commitment and 

work toward achieving HP2030’s vision 

of a society in which all people can 

achieve their full potential for health 

and well-being across the lifespan. 

HP2030 Champions. HP2030 

Champions can be public and private 

organizations such as those at the state, 

local, county, and tribal levels, nongovernmental organizations, non-profit 

organizations, businesses, academic 

organizations, organizations that impact 

health outcomes, philanthropic 

organizations, and tribal organizations 

that identify themselves as being 

aligned with or promoting HP2030, 

HP2030’s vision, and HP2030’s 

overarching goals. All organizations 

may apply. Applicants for HP2030 

Champions shall submit a letter of 

interest and identify how they address 

or support health promotion, disease 

prevention, social determinants of 

health (SDOH), health disparities, 

health equity, and/or well-being and 

work in alignment with HP2030 through 

activities, donations, or other means. 

Applicants for HP2030 Champions will 

be evaluated according to the 

organization’s commitment to support 

the overarching goals of Healthy People 

2030 and the Healthy People 2030 

objectives. Individuals are not eligible to 

be HP2030 Champions. 

HP2030 Champions will receive 

recognition from ODPHP on Health.gov/ 

healthypeople2030, a digital HP2030 

Champion badge for their website to 

highlight their support of HP2030, and 

HP2030 information, tools and 

resources for dissemination. 

The following activities may be 

considered as an organization’s 

demonstrated commitment to HP2030’s 

overarching goals and objectives: 

• Promoting and increasing access to 

disease prevention and health 

promotion activities; 

• Providing access to training or 

certification programs for disease 

prevention and health promotion; 

• Addressing SDOH, eliminating 

disparities, achieving health equity, 

and/or promoting well-being; 

• Providing training and other 

necessary resources to adapt or modify 

disease prevention and health 

promotion activities to meet the needs 

of diverse populations, address SDOH, 

eliminate disparities, achieve health 

equity, and/or promote well-being; 

• Developing partnerships across a 

variety of sectors, including business, 

community, academia, education, faithbased, government, health care, media, 

public health, and technology; 

• Working across sectors to address 

SDOH, eliminate disparities, and 

achieve health equity; 

• Evaluating health promotion and 

disease prevention programs or 

partnering with academic institutions or 

public health organizations to evaluate 

health promotion and disease 

prevention activities; 

• Including information in their 

public facing materials about programs 

for disease prevention, health 

promotion, addressing SDOH, 

eliminating disparities, achieving health 

equity, and/or promoting well-being in 

community needs assessments; 

• Adopting or implementing the 

HP2030 framework (i.e., vision, mission, 

overarching goals, foundational 

principles), Leading Health Indicators 

(LHIs), Overall Health and Well-Being 

Measures (OHMs) and/or HP2030 

objectives in their strategic plan; 

• Promoting HP2030; providing 

opportunities and venues for disease 

prevention and health promotion 

activities; 

• Partnering with national, state, 

tribal, or local volunteer organizations 

to provide education, training, or 

programs regarding health promotion, 

disease prevention, SDOH, health 

disparities, health equity, and wellbeing; 

• Supporting an entity with the 

responsibility to organize and 

coordinate efforts within and across 

sectors to foster health promotion and 

well-being; 

• Promoting collaboration across all 

levels, including neighborhoods, 

communities, tribes, cities, states, 

counties, and localities, to increase and 

expand participation in health 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 121 / Monday, June 28, 2021 / Notices 34027 

promotion and disease prevention 

activities; 

• Disseminating through a variety of 

platforms messaging about the benefits 

of and resources available to promote 

disease prevention, health promotion, 

well-being and the importance of 

addressing SDOH, health disparities, 

and health equity; 

• Supporting the coordination and 

standardization of data to enable 

comparisons across national, state, 

local, county, and/or tribal levels; 

• Providing grants, funding 

opportunities, and other resources to 

programs that address disease 

prevention, health promotion, wellbeing, SDOH, health equity, and health 

disparities. 

Funds: None. Neither HHS nor 

ODPHP will provide funds to support 

HP2030 Champions. Applicants and 

HP2030 Champions will not be 

expected to contribute funds. 

Application: Organizations may apply 

to be an HP2030 Champion. 

Organizations should submit a letter of 

interest acknowledging their support of 

the HP2030 vision of a society in which 

all people can achieve their full 

potential for health and well-being 

across the lifespan and HP2030’s 

overarching goals. Organizations 

interested in being HP2030 Champions 

shall identify in their letters of interest 

those activities from the list noted above 

that demonstrate commitment to 

HP2030’s overarching goals and 

objectives and indicate how they 

address or support health promotion, 

disease prevention, SDOH, health 

disparities, health equity, and wellbeing and work in alignment with 

HP2030 through activities, donations, or 

other means. 

DATES: Letters of interest to become a 

HP2030 Champion should be submitted 

to HP2030@hhs.gov. Letters of interest 

will be accepted starting on July 5, 2021 

and will be reviewed periodically. 

ODPHP will conduct an informational 

webinar for interested applicants on 

July 28, 2021, at 1 p.m. Eastern Time 

(ET); applicants interested in attending 

the informational webinar should 

register at https://healthypeople.

webex.com/healthypeople/onstage/

g.php?MTID=e97d3e46e4ec

8120606577daa5c72785a or https://

health.gov/healthypeople. 

ADDRESSES: Letters of interest can be 

submitted via email to HP2030@

hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Emmeline Ochiai, Office of Disease 

Prevention and Health Promotion, 

Office of the Assistant Secretary for 

Health, U.S. Department of Health and 

Human Services; 1101 Wootton 

Parkway, Suite 420, Rockville, MD 

20852; Telephone: (240) 453–8280. 

Email: HP2030@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background: Each decade since 1980, 

the Healthy People initiative has 

established and monitored national 

health objectives with 10-year targets to 

meet a broad range of health needs, 

encourage collaborations across sectors, 

guide individuals toward making 

informed health decisions, and measure 

the impact of disease prevention and 

health promotion activities. Launched 

August 2020, the current iteration— 

HP2030—leverages scientific insights 

and lessons from the past decade, along 

with the new knowledge of current data, 

trends, and innovations. HP2030 

provides science- and evidence-based, 

10-year national objectives for 

promoting health and preventing 

disease and sets targets to be achieved 

by the year 2030. It identifies public 

health priorities that address the major 

risks to health and well-being, and 

serves as a resource for preventing 

disease, promoting health, addressing 

SDOH, eliminating health disparities, 

and achieving health equity. HP2030 

reflects input from the Secretary’s 

Advisory Committee on National Health 

Promotion and Disease Prevention; the 

National Academies of Sciences, 

Engineering, and Medicine; a technical 

expert panel; subject matter experts 

from across HHS and other federal 

agencies; and members of the public via 

multiple public comment periods. On 

behalf of HHS, ODPHP leads and 

manages the development and 

implementation of HP2030. 

The HP2030 framework and 

objectives outline the nation’s plan for 

achieving the HP2030 vision of a society 

in which all people can achieve their 

full potential for health and well-being 

across the lifespan. HP2030’s framework 

includes its vision, mission, overarching 

goals, guiding foundational principles, 

and is supported by over 350 specific 

measurable objectives with targets, 

LHIs, and OHMs. HP2030 serves as a 

resource and provides user-centered 

tools for disease prevention and health 

promotion, including science-based 

objectives, national and populationlevel data, evidence-based resources, 

and SDOH literature summaries. 

Detailed information about HP2030 is 

available at https://health.gov/

healthypeople. 

Requirements of Interested 

Organizations 

ODPHP invites organizations that 

support HP2030, disease prevention, 

health promotion, and well-being and 

that demonstrate efforts toward 

addressing SDOH, eliminating health 

disparities, and achieving health equity 

in the United States to submit a letter of 

interest to become an HP2030 

Champion. 

HP2030 Champion. Organizations 

selected by ODPHP to be HP2030 

Champions will sign a letter of 

understanding (LOU) with ODPHP 

outlining the terms and parameters of 

their support for HP2030. Organizations 

selected to participate in the HP2030 

Champion program with an active LOU 

will be granted use of the digital 

HP2030 Champion badge as long as the 

organization continues to work in 

alignment with the HP2030. Use of the 

HP2030 Champion badge does not 

imply any federal endorsement of the 

collaborating organization’s general 

policies, activities, or products. 

Eligibility for Interested Organizations 

HP2030 Champion. To be eligible to 

become an HP2030 Champion, an 

organization shall: (1) Have a 

demonstrated interest in, understanding 

of, and experience with disease 

prevention, heath promotion, SDOH, 

health disparities, health equity, and/or 

well-being or (2) have an organizational 

or corporate mission that is aligned with 

the HP2030 vision, mission, overarching 

goals, foundational principles, or 

objectives; and (3) agree to sign a LOU 

with ODPHP, which will set forth the 

details of how the organization is 

supporting the vision of the HP2030. 

Letter of Interest Requirements 

HP2030 Champions. Each HP2030 

Champion letter of interest shall 

contain: (1) Organization name, 

location, website, and submitter’s 

contact information; (2) a brief 

description of the organization’s 

mission and/or values; and (3) a 

description of how the organization 

supports or plans to support the HP2030 

vision, such as addressing disease 

prevention, health promotion, SDOH, 

health disparities, health equity, wellbeing, prioritizing underserved 

populations, donating funds, or 

alignment with specific HP2030 

objectives, LHIs, or OHMs. 

Submission of a letter of interest does 

not guarantee acceptance as an HP2030 

Champion. ODPHP will review and 

evaluate letters of interest for alignment 

with the HP2030 vision. 

Authority: 42 U.S.C. 300u(a). 


khammond on DSKJM1Z7X2PROD with NOTICES
34028 Federal Register / Vol. 86, No. 121 / Monday, June 28, 2021 / Notices 

Dated: June 11, 2021. 

Paul Reed, 

Rear Admiral, U.S. Public Health Service, 

Deputy Assistant Secretary for Health, 

Director, Office of Disease Prevention and 

Health Promotion. 

[FR Doc. 2021–13667 Filed 6–25–21; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, PAR– 

20–181: Limited Competition: National 

Primate Research Centers (P51), July 01, 

2021, 10:00 a.m. to July 02, 2021, 06:00 

p.m., National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 which was 

published in the Federal Register on 

June 02, 2021, FR Doc 2021–11521, 86 

FR 29590. 

This meeting is being amended to 

change the start date from July 01, 2021 

to June 29, 2021 and the start time from 

10:00 a.m. to 12:30 p.m. The meeting is 

closed to the public. 

Dated: June 22, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–13690 Filed 6–25–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 20– 

243: Digital Healthcare Interventions to 

Address the Secondary Health Effects Related 

to Social, Behavioral and Economic Impact of 

COVID–19. 

Date: July 8, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Paul Hewett-Marx, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (240) 672–8946, hewettmarxpn@

csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 22, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–13689 Filed 6–25–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Cancer 

Center Support Grant (P30). 

Date: August 19, 2021. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W104, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: David G. Ransom, Ph.D., 

Chief, Special Review Branch, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W104, Rockville, Maryland 20850, 

240–276–6351, david.ransom@nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group; Cancer 

Centers Study Section (A). 

Date: August 20, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W530, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Shamala K. Srinivas, 

Ph.D., Associate Director, Office of Referral, 

Review, and Program Coordination, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W530, Rockville, Maryland 20892, 

240–276–6442, ss537t@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: June 22, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–13688 Filed 6–25–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the NIH Clinical Center 

Research Hospital Board. 

The meeting will be held as a virtual 

meeting and open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting should notify the 

Contact Person listed below in advance 

of the meeting. The meeting can be 

accessed from the NIH Videocast 

https://videocast.nih.gov/ and the 

CCRHB website https://

ccrhb.od.nih.gov/meetings.html. 

Name of Committee: NIH Clinical Center 

Research Hospital Board. 

Date: July 23, 2021. 

Time: 9:00 a.m. to 1:00 p.m. 

Agenda: Presentations of Mental Health 

Support, Ending Structural Racism, and The 

Hepatitis C Story. 


khammond on DSKJM1Z7X2PROD with NOTICES